Pure Raw Supplies files 13D for 100% stake in Nutra Pharma Series B
Pure Raw Supplies, LLC says it holds 100% of Nutra Pharma Corp’s Series B Preferred Shares after a bona fide gift on August 21, 2026. It filed a Schedule 13D on September 1, 2026, with no cash consideration.
Pure Raw Supplies, LLC disclosed ownership of 100% of Nutra Pharma Corp’s Series B Preferred Shares.
The firm received the shares as a bona fide gift on August 21, 2026, and filed a Schedule 13D on September 1, 2026.
The gift came from Rik Deitsch and involved no cash consideration, marking a chang…